Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | 120.35%656K | -12.51%986K | 65.29%-1.76M | -160.83%-3.48M | -21.21%3.68M | -0.34%-3.22M | 80.32%1.13M | -239.09%-5.07M | 338.83%5.73M | 224.39%4.67M |
| Net profit before non-cash adjustment | 42.28%1.47M | 10.33%908K | 5.74%1.53M | 50.23%4.02M | 183.18%719.03K | 41.34%1.04M | -7.42%823K | 80.17%1.45M | 139.91%2.68M | 23.13%253.91K |
| Total adjustment of non-cash items | -101.08%-3K | 68.04%326K | -22.43%211K | -7.28%960.36K | -45.19%216.36K | -7.64%278K | 67.24%194K | 21.43%272K | -24.95%1.04M | 31.09%394.78K |
| -Depreciation and amortization | -27.34%202K | -15.59%249K | -6.57%270K | -12.53%1.13M | -15.70%267.63K | -11.46%278K | -10.33%295K | -12.69%289K | -14.05%1.29M | -9.46%317.46K |
| -Reversal of impairment losses recognized in profit and loss | --0 | --0 | --0 | 124.01%13.23K | -34.47%20.23K | --0 | --0 | 91.86%-7K | -177.35%-55.12K | -60.55%30.88K |
| -Assets reserve and write-off | ---- | ---- | ---- | -97.03%572 | ---- | ---- | ---- | ---- | --19.24K | ---- |
| -Disposal profit | -16,300.00%-162K | 154.35%50K | --0 | 45.92%-96.27K | -125.19%-3.27K | 0.00%1K | 51.83%-92K | -100.00%-2K | -63.25%-178.02K | 111.90%12.98K |
| -Net exchange gains and losses | -57.14%3K | 6,500.00%64K | --1K | ---2.66K | ---8.66K | --7K | ---1K | --0 | --0 | --0 |
| -Other non-cash items | -475.00%-46K | -362.50%-37K | -650.00%-60K | -101.42%-84.15K | -522.97%-60.15K | 42.86%-8K | 63.64%-8K | 60.00%-8K | 50.53%-41.78K | 177.04%14.22K |
| Changes in working capital | 82.04%-815K | -325.45%-248K | 48.44%-3.5M | -520.69%-8.47M | -31.76%2.74M | -6.85%-4.54M | 128.95%110K | -359.23%-6.78M | 141.12%2.01M | 194.36%4.02M |
| -Change in receivables | 103.27%122K | -127.29%-116K | 39.30%-3.79M | -420.24%-7.93M | -61.25%1.62M | 11.95%-3.73M | 188.17%425K | -307.27%-6.25M | 205.89%2.48M | 259.93%4.18M |
| -Change in payables | -15.82%-937K | 58.10%-132K | 154.75%294K | -15.48%-535.78K | 816.81%1.13M | -6,641.67%-809K | -408.82%-315K | -35.26%-537K | 81.84%-463.98K | 90.48%-156.98K |
| -Changes in other current assets | ---- | ---- | ---- | --0 | -29.86%101K | --0 | ---- | ---- | --0 | --144K |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | 60.53%-15K | 68.97%-9K | 0.00%-2K | 133.33%1K | -25.00%-5K | -54.35%-38K | -1,007.29%-29K | |||
| Interest received (cash flow from operating activities) | -27.71%60K | 66.67%30K | -37.50%10K | -72.00%7K | -45.83%13K | -23.91%83K | -14.61%18K | |||
| Tax refund paid | 19.70%-269K | -4.01%-285K | -2.41%-298K | -24.62%-1.2M | -1.86%-302.35K | -2.45%-335K | -10.04%-274K | -216.30%-291K | -54.57%-964.83K | -56.05%-296.83K |
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | 110.88%387K | -17.82%701K | 61.61%-2.06M | -198.41%-4.69M | -21.77%3.38M | -0.94%-3.56M | 114.32%853K | -250.04%-5.36M | 262.10%4.76M | 209.96%4.32M |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | --0 | 89.35%-57K | -371.43%-38K | -328.80%-635.45K | -780.92%-114.45K | --0 | -287.68%-535K | 166.67%14K | 37.11%-148.19K | 136.05%16.81K |
| Net intangibles purchase and sale | ---- | ---- | ---- | -326.61%-1M | ---- | ---- | ---- | ---- | 190.89%441.77K | ---- |
| Net business purchase and sale | --0 | ---- | ---- | ---15K | --0 | --0 | ---- | ---- | --0 | --0 |
| Interest received (cash flow from investment activities) | 340.00%44K | 471.43%40K | 261.54%47K | -28.09%59.52K | --29.52K | --10K | --7K | --13K | --82.77K | ---- |
| Net changes in other investments | 58,200.00%583K | --56K | ---995K | -326.47%-1M | --0 | 200.00%1K | ---- | ---- | --442K | --1K |
| Investing cash flow | 5,600.00%627K | 102.52%39K | -3,751.85%-986K | -523.02%-1.59M | -184.70%-84.99K | 257.14%11K | -608.22%-1.55M | 228.57%27K | 152.15%376.34K | -7.38%100.34K |
| Financing cash flow | ||||||||||
| Net common stock issuance | --0 | --0 | 491.05%1.52M | 898.20%11.43M | 236.74%3.55M | 24,764.00%6.17M | 158.10%1.46M | 335.59%257K | -269.07%-1.43M | 371.41%1.05M |
| Increase or decrease of lease financing | 2.22%-88K | 10.31%-87K | 12.24%-86K | 6.24%-368.82K | -6.97%-83.82K | 15.09%-90K | 7.62%-97K | 5.77%-98K | 1.49%-393.36K | 25.59%-78.36K |
| Interest paid (cash flow from financing activities) | -250.00%-7K | -900.00%-8K | -80.00%-9K | 60.18%-15.05K | ---9.05K | ---2K | --1K | ---5K | ---37.79K | ---- |
| Net other fund-raising expenses | ---- | ---- | ---- | --4K | ---- | ---- | ---- | ---- | ---- | ---- |
| Financing cash flow | -101.56%-95K | -106.94%-95K | 824.68%1.42M | 692.95%11.05M | 268.56%3.45M | 4,736.64%6.07M | 152.11%1.37M | 442.22%154K | -136.67%-1.86M | 289.95%937.32K |
| Net cash flow | ||||||||||
| Beginning cash position | 235.88%11.73M | 296.02%11.15M | 59.76%12.77M | 69.39%7.99M | 127.99%6.01M | -44.57%3.49M | -65.77%2.82M | 69.39%7.99M | -48.52%4.72M | -70.79%2.64M |
| Current changes in cash | -63.63%919K | -4.59%645K | 68.73%-1.62M | 45.78%4.77M | 25.99%6.75M | 168.99%2.53M | 135.15%676K | -247.70%-5.18M | 173.63%3.27M | 224.21%5.36M |
| Effect of exchange rate changes | 57.14%-3K | -6,500.00%-64K | ---1K | --2.68K | --8.68K | ---7K | --1K | --0 | --0 | ---- |
| Cash adjustments other than cash changes | ---- | ---- | ---- | ---- | ---- | ---7K | ---- | ---- | ---- | ---- |
| End cash Position | 110.33%12.65M | 235.88%11.73M | 296.02%11.15M | 59.75%12.77M | 59.75%12.77M | 127.99%6.01M | -44.57%3.49M | -65.77%2.82M | 69.39%7.99M | 69.39%7.99M |
| Free cash flow | 110.87%387K | 105.75%644K | 60.94%-2.1M | -249.99%-6.65M | -54.36%1.96M | -0.82%-3.56M | 140.77%313K | -251.31%-5.36M | 211.83%4.44M | 190.02%4.29M |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.